We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+12.75%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$104B
AUM Growth
+$8.72B
Cap. Flow
-$256M
Cap. Flow %
-0.25%
Top 10 Hldgs %
26.49%
Holding
4,372
New
62
Increased
2,195
Reduced
1,544
Closed
71

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$35.4M
2
P
Everpure Inc
P
+$21M
3
NVDA icon
NVIDIA
NVDA
+$20.7M
4
AMH icon
American Homes 4 Rent
AMH
+$19.3M
5
DAY
Dayforce
DAY
+$19M

Sector Composition

Rank Sector Weight
1 Technology 28.42%
2 Financials 13.09%
3 Healthcare 11.94%
4 Consumer Discretionary 10.95%
5 Industrials 9.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ASLE icon
2776
AerSale
ASLE
$279M
$334K ﹤0.01%
46,533
+3,816
+9% +$35.2K
UTMD icon
2777
Utah Medical Products
UTMD
$225M
$334K ﹤0.01%
4,696
+158
+3% +$11.9K
WEST icon
2778
Westrock Coffee
WEST
$803M
$332K ﹤0.01%
32,188
+865
+3% +$8.73K
DXLG icon
2779
Destination XL Group
DXLG
$35.4M
$332K ﹤0.01%
92,339
+2,274
+3% +$8.92K
NEWT icon
2780
NewtekOne
NEWT
$391M
$331K ﹤0.01%
30,048
+974
+3% +$11.5K
CIFR icon
2781
Cipher Digital
CIFR
$7.13B
$330K ﹤0.01%
64,156
-821
-1% -$2.84K
NRIM icon
2782
Northrim BanCorp
NRIM
$587M
$330K ﹤0.01%
26,136
+800
+3% +$10.1K
FORR icon
2783
Forrester Research
FORR
$224M
$330K ﹤0.01%
15,290
-18,132
-54% -$411K
ONC
2784
BeOne Medicines Ltd
ONC
$39.4B
$329K ﹤0.01%
2,101
-869
-29% -$140K
GLUE icon
2785
Monte Rosa Therapeutics
GLUE
$1.35B
$328K ﹤0.01%
46,553
+1,193
+3% +$7.08K
GRTS
2786
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$327K ﹤0.01%
127,423
+3,747
+3% +$9.15K
FMS icon
2787
Fresenius Medical Care
FMS
$12.9B
$327K ﹤0.01%
16,939
+1,763
+12% +$34.9K
LXRX icon
2788
Lexicon Pharmaceuticals
LXRX
$1.1B
$324K ﹤0.01%
134,845
+4,554
+3% +$9.78K
ACTG icon
2789
Acacia Research
ACTG
$470M
$321K ﹤0.01%
60,191
-3,967
-6% -$16.6K
HOFT icon
2790
Hooker Furnishings Corp
HOFT
$166M
$320K ﹤0.01%
13,324
-894
-6% -$21.4K
WLFC icon
2791
Willis Lease Finance
WLFC
$1.29B
$319K ﹤0.01%
19,296
+915
+5% +$14.7K
JMSB icon
2792
John Marshall Bancorp
JMSB
$329M
$318K ﹤0.01%
17,740
+524
+3% +$9.88K
TWKS
2793
DELISTED
Thoughtworks Holding, Inc. Common Stock
TWKS
$317K ﹤0.01%
125,353
-3
-0% -$12
AGEN
2794
Agenus
AGEN
$290M
$317K ﹤0.01%
27,331
+1,190
+5% +$15.8K
INGN icon
2795
Inogen
INGN
$164M
$316K ﹤0.01%
39,202
+934
+2% +$6.61K
YALA
2796
Yalla Group
YALA
$832M
$316K ﹤0.01%
65,688
+17,231
+36% +$88.7K
ERIC icon
2797
Ericsson
ERIC
$33.3B
$314K ﹤0.01%
57,014
+7,625
+15% +$43K
TDK
2798
DELISTED
TDK CORP AMER DEP SH
TDK
$314K ﹤0.01%
6,383
+972
+18% +$47.8K
ALCO icon
2799
Alico
ALCO
$283M
$312K ﹤0.01%
10,673
+165
+2% +$4.71K
ITIC
2800
Investors Title Co
ITIC
$547M
$312K ﹤0.01%
1,914
+4
+0.2% +$642

Similar funds

RhumbLine Advisers's Q1 2024 Portfolio in Review

As of Q1 2024, RhumbLine Advisers held 4,372 positions worth $104B, up 9.1% from $95.4B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Trading was light in Q1 2024: portfolio turnover was 3%. RhumbLine Advisers opened 62 new positions and exited 71, leaving the 4,372-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 28% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q1 2024 buy was Dayforce: 278,394 shares worth $18.4M.
  • RhumbLine Advisers added most to Amazon in Q1 2024, an estimated $35.4M increase.
  • RhumbLine Advisers's biggest Q1 2024 reduction was Procter & Gamble, cutting an estimated $46.7M.
  • RhumbLine Advisers fully exited Splunk Inc in Q1 2024, selling an estimated $32.3M.
  • RhumbLine Advisers's ten largest holdings make up 26% of its $104B portfolio in Q1 2024.
  • RhumbLine Advisers opened 62 new positions and closed 71 in Q1 2024.
  • RhumbLine Advisers's portfolio value rose 9.1% quarter-over-quarter to $104B.

Based on RhumbLine Advisers's 13F filing for Q1 2024, filed 9 May 2024.